Dopamine and basal ganglia disorders in humans
暂无分享,去创建一个
[1] J. Deniau,et al. Disinhibition as a basic process in the expression of striatal functions , 1990, Trends in Neurosciences.
[2] P. Brotchie,et al. Motor function of the monkey globus pallidus. 2. Cognitive aspects of movement and phasic neuronal activity. , 1991, Brain : a journal of neurology.
[3] D. Weinberger,et al. Dopamine and schizophrenia—a cortically corrective perspective , 1992 .
[4] C. Marsden,et al. 'Subcortical dementia': the neuropsychological evidence. , 1988, Neuroscience.
[5] C. Marsden,et al. Disturbance of sequential movements in patients with Parkinson's disease. , 1987, Brain : a journal of neurology.
[6] C. Marsden. Parkinson's disease , 1940, The Lancet.
[7] P. Goldman-Rakic. Dopamine-mediated mechanisms of the prefrontal cortex , 1992 .
[8] R. G. Robertson,et al. Dyskinesia in the primate following injection of an excitatory amino acid antagonist into the medial segment of the globus pallidus , 1989, Brain Research.
[9] G. Percheron,et al. A Golgi analysis of the primate globus pallidus. III. Spatial organization of the striato‐pallidal complex , 1984, The Journal of comparative neurology.
[10] J. Penney,et al. The functional anatomy of basal ganglia disorders , 1989, Trends in Neurosciences.
[11] L. Henderson,et al. Abnormalities of nonvisually-guided eye movements in Parkinson's disease. , 1989, Brain : a journal of neurology.
[12] I. Mitchell,et al. Common neural mechanisms in experimental chorea and hemiballismus in the monkey. Evidence from 2-deoxyglucose autoradiography , 1985, Brain Research.
[13] M. Delong,et al. Primate models of movement disorders of basal ganglia origin , 1990, Trends in Neurosciences.
[14] Marsden Cd. What do the basal ganglia tell premotor cortical areas , 1987 .
[15] R. Wurtz,et al. Visual and oculomotor functions of monkey substantia nigra pars reticulata. IV. Relation of substantia nigra to superior colliculus. , 1983, Journal of neurophysiology.
[16] G. E. Alexander,et al. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. , 1986, Annual review of neuroscience.
[17] O. Hornykiewicz. Dopamine (3-hydroxytyramine) and brain function. , 1966, Pharmacological reviews.
[18] T. Robbins,et al. Planning and spatial working memory in Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[19] H. Bergman,et al. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. , 1990, Science.
[20] R. Wurtz,et al. Visual and oculomotor functions of monkey substantia nigra pars reticulata. II. Visual responses related to fixation of gaze. , 1983, Journal of neurophysiology.
[21] T. Bonner,et al. Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[22] C. Gerfen,et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. , 1990, Science.
[23] G. E. Alexander,et al. Functional architecture of basal ganglia circuits: neural substrates of parallel processing , 1990, Trends in Neurosciences.
[24] C. Marsden,et al. Cognitive function in Parkinson's disease: From description to theory , 1990, Trends in Neurosciences.
[25] J. Penney,et al. Differential loss of striatal projection neurons in Huntington disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[26] A Jackson,et al. Chorea and myoclonus in the monkey induced by gamma-aminobutyric acid antagonism in the lentiform complex. The site of drug action and a hypothesis for the neural mechanisms of chorea. , 1988, Brain : a journal of neurology.
[27] J. D. Parkes,et al. "ON-OFF" EFFECTS IN PATIENTS WITH PARKINSON'S DISEASE ON CHRONIC LEVODOPA THERAPY , 1976, The Lancet.
[28] J. Penney,et al. γ‐Aminobutyric Acid and Benzodiazepine Receptor Changes Induced by Unilateral 6‐Hydroxydopamine Lesions of the Medial Forebrain Bundle , 1985, Journal of neurochemistry.
[29] W T Thach,et al. Basal ganglia motor control. III. Pallidal ablation: normal reaction time, muscle cocontraction, and slow movement. , 1991, Journal of neurophysiology.
[30] A. C. Roberts,et al. Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: Evidence for a specific attentional dysfunction , 1989, Neuropsychologia.
[31] R. Wurtz,et al. Modification of saccadic eye movements by GABA-related substances. I. Effect of muscimol and bicuculline in monkey superior colliculus. , 1985, Journal of neurophysiology.
[32] R. G. Robertson,et al. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine , 1989, Neuroscience.
[33] J R WHITTIER,et al. Analysis of choreoid hyperkinesia in the rhesus monkey. Surgical and pharmacological analysis of hyperkinesia resulting from lesions in the subthalamic nucleus ol luys , 1950, The Journal of comparative neurology.
[34] J. Saint-Cyr,et al. Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow. , 1986, Brain : a journal of neurology.
[35] O. Hikosaka,et al. Functional properties of monkey caudate neurons. I. Activities related to saccadic eye movements. , 1989, Journal of neurophysiology.
[36] A. Lees,et al. Cognitive deficits in the early stages of Parkinson's disease. , 1983, Brain : a journal of neurology.
[37] C. Kennard,et al. Predictive ocular motor control in Parkinson's disease. , 1985, Brain : a journal of neurology.
[38] C. Marsden,et al. Cognitive performance in multiple system atrophy. , 1992, Brain : a journal of neurology.
[39] G. E. Alexander,et al. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. , 1990, Progress in brain research.
[40] T. Aziz,et al. Lesion of the subthalamic nucleus for the alleviation of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced parkinsonism in the primate , 1991, Movement disorders : official journal of the Movement Disorder Society.
[41] W. T. Thach,et al. Basal ganglia motor control. II. Late pallidal timing relative to movement onset and inconsistent pallidal coding of movement parameters. , 1991, Journal of neurophysiology.
[42] C. Marsden,et al. 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. , 1988, Brain : a journal of neurology.
[43] P. Brotchie,et al. Motor function of the monkey globus pallidus. 1. Neuronal discharge and parameters of movement. , 1991, Brain : a journal of neurology.
[44] C. Marsden,et al. SUCCESS AND PROBLEMS OF LONG-TERM LEVODOPA THERAPY IN PARKINSON'S DISEASE , 1977, The Lancet.
[45] S. Dunnett. Transplantation of dopamine neurons , 1992 .
[46] F Lhermitte,et al. Does long‐term aggravation of Parkinson's disease result from nondopaminergic lesions? , 1987, Neurology.
[47] C. Gerfen. D1 and D2 dopamine receptor regulation of striatonigral and striatopallidal neurons , 1992 .
[48] R. Wurtz,et al. Visual and oculomotor functions of monkey substantia nigra pars reticulata. III. Memory-contingent visual and saccade responses. , 1983, Journal of neurophysiology.
[49] W. T. Thach,et al. Basal ganglia motor control. I. Nonexclusive relation of pallidal discharge to five movement modes. , 1991, Journal of neurophysiology.
[50] R. Wurtz,et al. Visual and oculomotor functions of monkey substantia nigra pars reticulata. I. Relation of visual and auditory responses to saccades. , 1983, Journal of neurophysiology.
[51] R. Wurtz,et al. Modification of saccadic eye movements by GABA-related substances. II. Effects of muscimol in monkey substantia nigra pars reticulata. , 1985, Journal of neurophysiology.
[52] T. Robbins,et al. Planning and spatial working memory following frontal lobe lesions in man , 1990, Neuropsychologia.
[53] E. Sullivan,et al. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. , 1991, Brain : a journal of neurology.